vs
FIDELITY D & D BANCORP INC（FDBC）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
FIDELITY D & D BANCORP INC的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$24.4M vs $19.6M），FIDELITY D & D BANCORP INC净利率更高（32.5% vs -177.4%，领先209.9%），FIDELITY D & D BANCORP INC同比增速更快（15.0% vs -11.5%），FIDELITY D & D BANCORP INC自由现金流更多（$24.8M vs $-23.1M），过去两年FIDELITY D & D BANCORP INC的营收复合增速更高（11.8% vs -12.2%）
Fidelity D & D Bancorp Inc是一家总部位于美国的地区性银行控股公司，主要在宾夕法尼亚州东北部开展业务，为个人消费者、小微企业及当地社区客户提供存款账户、消费及商业贷款、抵押贷款、财富管理等综合零售及商业银行服务。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FDBC vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.4M | $19.6M |
| 净利润 | $7.9M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 37.7% | -168.5% |
| 净利率 | 32.5% | -177.4% |
| 营收同比 | 15.0% | -11.5% |
| 净利润同比 | 36.1% | -28.8% |
| 每股收益（稀释后） | $1.29 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $24.4M | — | ||
| Q3 25 | $23.5M | $19.6M | ||
| Q2 25 | $23.3M | $21.8M | ||
| Q1 25 | $22.0M | $40.8M | ||
| Q4 24 | $21.2M | — | ||
| Q3 24 | $20.4M | $22.1M | ||
| Q2 24 | $19.7M | $22.5M | ||
| Q1 24 | $19.5M | $45.5M |
| Q4 25 | $7.9M | — | ||
| Q3 25 | $7.3M | $-34.7M | ||
| Q2 25 | $6.9M | $-33.5M | ||
| Q1 25 | $6.0M | $-26.0M | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $5.0M | $-26.9M | ||
| Q2 24 | $4.9M | $-45.7M | ||
| Q1 24 | $5.1M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | 37.7% | — | ||
| Q3 25 | 36.5% | -168.5% | ||
| Q2 25 | 35.5% | -118.1% | ||
| Q1 25 | 32.2% | -80.8% | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.2% | -120.9% | ||
| Q2 24 | 28.9% | -134.5% | ||
| Q1 24 | 29.5% | -132.2% |
| Q4 25 | 32.5% | — | ||
| Q3 25 | 31.2% | -177.4% | ||
| Q2 25 | 29.7% | -153.7% | ||
| Q1 25 | 27.2% | -63.8% | ||
| Q4 24 | 27.5% | — | ||
| Q3 24 | 24.3% | -122.0% | ||
| Q2 24 | 25.0% | -203.3% | ||
| Q1 24 | 25.9% | -70.6% |
| Q4 25 | $1.29 | — | ||
| Q3 25 | $1.27 | $-0.09 | ||
| Q2 25 | $1.27 | $-0.09 | ||
| Q1 25 | $1.03 | $-0.07 | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $0.86 | $-0.07 | ||
| Q2 24 | $0.86 | $-0.12 | ||
| Q1 24 | $0.88 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $238.9M | $399.7M |
| 总资产 | $2.7B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $148.1M | — | ||
| Q3 25 | $142.2M | $129.4M | ||
| Q2 25 | $165.5M | $158.6M | ||
| Q1 25 | $211.2M | $150.9M | ||
| Q4 24 | $83.4M | — | ||
| Q3 24 | $120.2M | $210.6M | ||
| Q2 24 | $78.1M | $269.8M | ||
| Q1 24 | $72.7M | $287.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $238.9M | — | ||
| Q3 25 | $229.2M | $399.7M | ||
| Q2 25 | $217.9M | $424.5M | ||
| Q1 25 | $211.7M | $454.6M | ||
| Q4 24 | $204.0M | — | ||
| Q3 24 | $207.3M | $489.3M | ||
| Q2 24 | $195.7M | $510.3M | ||
| Q1 24 | $191.6M | $577.3M |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $539.6M | ||
| Q2 25 | $2.7B | $557.0M | ||
| Q1 25 | $2.7B | $579.6M | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | $681.5M | ||
| Q2 24 | $2.5B | $708.7M | ||
| Q1 24 | $2.5B | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $24.8M | $-23.1M |
| 自由现金流率自由现金流/营收 | 101.7% | -118.1% |
| 资本支出强度资本支出/营收 | 71.9% | 4.5% |
| 现金转化率经营现金流/净利润 | 5.34× | — |
| 过去12个月自由现金流最近4个季度 | $45.4M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $42.4M | — | ||
| Q3 25 | $8.4M | $-22.2M | ||
| Q2 25 | $12.6M | $-20.7M | ||
| Q1 25 | $11.7M | $-30.3M | ||
| Q4 24 | $29.6M | — | ||
| Q3 24 | $9.1M | $-27.9M | ||
| Q2 24 | $8.7M | $-39.0M | ||
| Q1 24 | $5.3M | $-62.5M |
| Q4 25 | $24.8M | — | ||
| Q3 25 | $2.2M | $-23.1M | ||
| Q2 25 | $6.9M | $-22.6M | ||
| Q1 25 | $11.5M | $-35.3M | ||
| Q4 24 | $24.9M | — | ||
| Q3 24 | $7.8M | $-30.1M | ||
| Q2 24 | $7.2M | $-41.0M | ||
| Q1 24 | $4.0M | $-63.3M |
| Q4 25 | 101.7% | — | ||
| Q3 25 | 9.3% | -118.1% | ||
| Q2 25 | 29.6% | -103.6% | ||
| Q1 25 | 52.3% | -86.6% | ||
| Q4 24 | 117.3% | — | ||
| Q3 24 | 38.1% | -136.4% | ||
| Q2 24 | 36.6% | -182.2% | ||
| Q1 24 | 20.7% | -138.9% |
| Q4 25 | 71.9% | — | ||
| Q3 25 | 26.5% | 4.5% | ||
| Q2 25 | 24.4% | 8.7% | ||
| Q1 25 | 0.8% | 12.4% | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 6.3% | 10.2% | ||
| Q2 24 | 7.5% | 8.6% | ||
| Q1 24 | 6.7% | 1.7% |
| Q4 25 | 5.34× | — | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.82× | — | ||
| Q1 25 | 1.95× | — | ||
| Q4 24 | 5.07× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDBC
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
